3 ISA Buys With Big Growth Potential? GlaxoSmithKline plc, easyJet plc, And SKY PLC

Will GlaxoSmithKline plc (LON:GSK), easyJet plc (LON:EZJ) and SKY PLC (LON:SKY) boost your ISA profits next year?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With only two more trading days left until the end of the tax year, it’s not too late to top up your ISA with some high-quality dividend growth stocks. In today’s article I’ll look at three major companies and ask whether these big cap stocks have the potential to deliver big growth.

An unbeatable buy?

GlaxoSmithKline (LSE: GSK) is one of the largest holdings in my personal portfolio, so I may be biased. But I don’t think I’m wrong.

The UK’s largest pharma stock has now completed a restructuring programme which saw it generate £2bn of sales from new products last year. That total is expected to reach £6bn by 2018. Alongside this, Glaxo expects to deliver £3bn of annual cost savings by 2017.

The result should be a leaner business with improved growth potential. The company will also get a new chief executive in March 2017, when current boss Sir Andrew Witty is set to retire.

In the meantime, Glaxo’s 80p per share dividend gives a yield of 5.7%. Net debt has fallen and earnings are expected to rise this year, making Glaxo’s generous dividend look more affordable than it did last year. In my view, now could be a very good time to build a long-term holding in GlaxoSmithKline.

Flying high, but for how long?

Shares in budget airline easyJet (LSE: EZJ) have fallen by 13% so far this year and by 20% over the last twelve months. The falls have come despite the group reporting rising passenger numbers, stable sales and rising profits.

easyJet’s adjusted earnings per share are expected to rise by 7% this year to 148.4p. This puts the stock on a forecast P/E of 10. There’s also an attractive 65.6p forecast dividend, giving a potential yield of 4.3%.

Current forecasts suggest that earnings growth will accelerate in 2017. Analysts have pencilled in a solid 15% rise in earnings to 170.7p per share.

So why does easyJet seem to be so cheap? One reason is that the airline industry is notoriously cyclical. easyJet shares have risen by 320% over the last five years, during which profits have more than doubled.  It may be that the market is pricing in a slowdown in this rate of growth. Other airline shares have also cooled this year.

However, easyJet’s valuation doesn’t seem demanding. The low-cost model seems to be here to stay. I’m tempted to say that at around 1,500p, easyJet could be a profitable buy.

An uncertain picture

Between October and December 2015, a whopping 337,000 new customers joined Sky (LSE: SKY), the highest level of UK and Ireland growth for ten years.

However, this influx of new customers isn’t expected to result in a surge in profits this year. Current forecasts suggest that Sky’s earnings per share will fall by 9.5% to 62p for the year ending 30 June. A further 7.3% decline is forecast for 2016/17.

One reason for this may be the short-term cost of reducing the group’s £6bn net debt, which is largely the result of Sky’s acquisition of Sky Deutschland and Sky Italia in 2014. Sky has always generated a lot of free cash flow, but reducing the group’s debt will still be a demanding challenge.

Given Sky’s high gearing and the lacklustre outlook for earnings growth, I’m tempted to tune in elsewhere. Sky’s forecast P/E of 16.5 and the firm’s 3.4% forecast dividend don’t seem like bargains to me.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and Sky. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

A cheap FTSE 100 share that’s tipped to rebound sharply in 2025!

Recent price weakness means this FTSE share now offers stunning all-round value. I think it could experience a strong recovery…

Read more »

Light bulb with growing tree.
Investing Articles

2 sinking FTSE 100 shares I think could rebound in 2025!

Warren Buffett loves buying beaten-down stocks in anticipation of a price recovery. Here are two from the FTSE 100 that've…

Read more »

British Pennies on a Pound Note
Investing Articles

1 near-penny stock I’m buying for the last time at 19p

Our writer explains why a penny stock he bought a couple of years ago has taken a big dip since…

Read more »

Investing Articles

3 ETFs to consider buying for a 16% average annual return!

Searching for double-digit annual returns? These top exchange-traded funds (ETFs) could help investors build substantial long-term wealth.

Read more »

Middle-aged black male working at home desk
Investing Articles

2 top ETFs I’m considering buying for my SIPP in 2025!

Exchange-traded funds (ETFs) can be a great way to spread risk AND target market-beating returns. Here's a couple I have…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

3 top S&P 500 growth shares to consider buying for a Stocks and Shares ISA in 2025

Edward Sheldon has picked out three S&P 500 stocks that he believes will provide attractive returns for investors in the…

Read more »

Growth Shares

Can the red hot Scottish Mortgage share price smash the FTSE 100 again in 2025?

The Scottish Mortgage share price moved substantially higher in 2024. Edward Sheldon expects further gains next year and in the…

Read more »

Inflation in newspapers
Investing Articles

2 inflation-resistant growth stocks to consider buying in 2025

Rising prices are back on the macroeconomic radar, meaning growth prospects are even more important for investors looking for stocks…

Read more »